Mucopolysaccharidosis Type I (MPS I) is a rare genetic disorder that disrupts the body's ability to break down glycosaminoglycans (GAGs), leading to severe organ and tissue damage. While traditional treatments like enzyme replacement therapy (ERT) have provided significant benefits, the search for more effective and long-lasting therapies continues. In this article, we will explore...